4H-1-Benzopyran-4-one,2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-
CAS: 7085-55-4
Ref. IN-DA00IC3Y
1g | 27,00 € | ||
5g | 53,00 € | ||
25g | 147,00 € | ||
100g | 299,00 € | ||
250g | 563,00 € | ||
250mg | 25,00 € |
- Arzneimittelwirkstoffe (API) für Forschungszwecke
- Biochemikalien und Reagenzien
- Zelluläre und molekulare Biologie
- Disaccharide
- Flavonoide
- Funktionelle Oligosaccharide
- Glykowissenschaften
- Natürliche Glykoside
- Naturprodukte und phytochemische Stoffe botanischen Ursprungs
- Ernährungsforschung
- Phenole
- Phytochemikalien
- Polyphenol
Produktinformation
- 3',4',7-trihydroxyethylrutin
- 3',4',7-tris(O-(2- hydroxyethyl))rutin
- oxerutin
- Paroven
- Posorutin
- Relvene
- Rhéoflux
- Teboven
- Troxérutine Mazal
- troxerutin
- Mehr Synonyme anzeigen
- Troxerutin-ratiopharm
- Troxeven
- Vastribil
- Veinamitol
- Veniten retard
- Venorutin
- venoruton
- Venotrulan Trox
- Troxerutin
- Troxerutine
- Trioxyethylrutin
- Posorutin
- Factor P-zyma
- Trihydroxyethylrutin
- Tris(hydroxyethyl)rutin
- Tris(hydroxyethyl)rutoside
- 3',4',7-Tris(hydroxyethyl)rutin
- Pherarutin
- Vastribil
- Veinamitol
- Troksevazin
- Troxarutin
- Helveton
- Venaroid
- Veniten
- Flebil
- Ruven
- Pur-Rutin
- Veinamitol Pulver
- Troxarutin-ratiopharm
- Trihydroxyethylrutoside [French]
- Troxerutina
- Troxerutinum
- 3,5-Dihydroxy-3',4',7-tris(2-hydroxyethoxy)flavone 3-rutinoside
- 7,3',4'-Tris(O-(2-hydroxyethyl)rutin
- Trihydroxyethylrutoside
- Venoruton gel
- Troxerutin,(S)
- 2-(3,4-bis(2-hydroxyethoxy)phenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)methyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one
- Tris-O-(2-hydroxyethyl)rutin
- Tris-O-(b-hydroxyethyl)rutoside
- Flavone, 3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-, 3-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside)
- 3',4',7-Tri-O-(b-hydroxyethyl)rutoside
- O-(beta-hydroxyethyl)-tutinosides (mixture)
- rahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
- 2-(3,4-bis(2-hydroxyethoxy)phenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tet
- 2-(3,4-bis(2-hydroxyethoxy)phenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
- 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
- 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxymethyl]-2-oxanyl]oxy]-1-benzopyran-4-one
- 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
- 2-[3,4-bis(2-hydroxyethyloxy)phenyl]-7-(2-hydroxyethyloxy)-3-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5R,6S)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-oxidanyl-chromen-4-one
- 3-[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranoside]3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-Flavone
- 2-[3,4-Bis(2-hydroxyethoxy)phenyl]-3-[[6-O-(6-deoxy-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)-β-<smallcap>D</span>-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-4H-1-benzopyran-4-one
- 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-D-glucopyranoside
- 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-4-oxo-4H-chromen-3-yl 6-O-(6-deoxyhexopyranosyl)hexopyranoside
- 3',4',7-Tris[O-(2-hydroxyethyl)]rutin
- 3,5-Dihydroxy-3′,4′,7-tris(2-hydroxyethoxy)flavone 3-rutinoside
- 3′,4′,7-Tri-O-(β-hydroxyethyl)rutoside
- 3′,4′,7-Tris(hydroxyethyl)rutin
- 4H-1-Benzopyran-4-one, 2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-O-(6-deoxy-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)-β-<smallcap>D</span>-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-
- Factor P-Zyma
- Flavone, 3,5-dihydroxy-3′,4′,7-tris(2-hydroxyethoxy)-, 3-[6-O-(6-deoxy-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)-β-<smallcap>D</span>-glucopyranoside]
- Rufen-P4
- Toxerutin
- TriHER
- Trihydroxylrutin
- Tris-O-(β-hydroxyethyl)rutoside
- Troxevazin
- Venoruton P<sub>4</sub>
- Vitamin P<sub>4</sub>
- Z 6000
Chemische Eigenschaften
Technische Anfrage zu: IN-DA00IC3Y 4H-1-Benzopyran-4-one,2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.